SBIR/STTR Research Award

A screening assay for chemicals that affect the differentiation of human neural cells.

Award identifier e319b3ed5d5f5a399708122aaea38937977b900915310035e9bf70495300ef40Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,985

Program and phase

STTR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NZUMBE INC
Proposal award date
2015-09-30
Contract end date
2016-08-31
UEI
NSVYJ517CHC5
Solicitation number
ES15-005
Topic code
NIEHS

Research abstract

DESCRIPTION provided by applicant Human brain development represents a highly vulnerable time to chemical exposures because immature cells are actively undergoing differentiation into more complex cell types e g neurons astrocytes oligodendroglia to form neural circuits A major reason for this vulnerability is that neuronal differentiation requires critical time dependent changes to the epigenome i e neuroepigenetics and environmental exposures pose acute risks to the epigenomes of actively differentiating cells Significantly abnormal brain develop from epigenomic perturbation is believed to be an underlying cause of several neurological disorders including autism and schizophrenia Despite this risk however the identity of chemicals present in our environment that affect human neuronal differentiation and do so by perturbing developing epigenomes is lagging Nzumbe Inc is responding to RFA ES entitled andquot Novel Assays for Screening the Effects of Chemical Toxicants on Cell Differentiationandquot with an application to develop a screening assay to identify chemicals that interfere with the process of neural differentiation Our focus will be on chemicals that perturb epigenetic mechanisms because of their potential to stably and aberrantly affect brain development We will use markers of neuronal and glial cell differentiation to identify effects from chemical exposures Two specific aims are proposed The first aim will use human neuroprogenitor neural stem cells hNPCs derived from human iPS cells to establish time points of interest as the hNPCs differentiate into cell subtypes recapitulating normal human brain development This work will be performed with hNPCs undergoing proliferation and differentiation in well plates to facilitate automated screening Fluorescent labeled antibodies will allow for automated screening to distinguish the different cell subtypes that arise at each time point tested and their relative proportions in the total cell population The work proposed in aim will test the effects of five chemicals with known and suspected epigenetic activities for their ability to perturb normal differentiation as described in aim These chemicals include two well characterized epigenetic inhibitors deoxyazacytdine and trichostatin A which inhibit DNA methylation and histone deacetylation respectively as initial controls Next we will test two chemicals on the tox list valproic acid and Bisphenol A which can perturb epigenomes and alter brain development and a third chemical methylazoxymethanol which has clear effects on neuronal development and is both a metabolite and precursor of several chemicals on the tox list The proposed work will identify discrete time points and cell specific markers that can be used to screen for aberrant changes in neuronal differentiation following exposures to chemicals with epigenetic activities This work will lead to a well defined assay that can be commercialized in a phase II funded program PUBLIC HEALTH RELEVANCE The period of active neuronal differentiation is particularly sensitive to chemical exposures However screening assays for such chemicals still need to be developed The objective of this application is to develop a screening assay to identify chemicals that perturb neuronal differentiation with a focus on chemicals that do so via epigenetic activities

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

6 SBIR/STTR records share this UEI (2014–2023). Reported award amounts total $3,753,928. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.